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Attenuation of NMDA Receptor Activity
and Neurotoxicity by Nitroxyl Anion, NO2
by hemoglobin (Gow and Stamler, 1998), neuronal nitric
oxide synthase (NOS) (Hobb et al., 1994; Pufahl et al.,
1995; Zhao et al., 1995; Schmidt et al., 1996), and endog-
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NMDA receptor activity. We further show that NO2 ef-
fects are mimicked by NOS activity, and we suggest a
new therapeutic approach, using NO2 donors, to amelio-Summary
rate NMDA receptor-mediated neuronal damage.
Recent evidence indicates that the NO-related spe-
cies, nitroxyl anion (NO2), is produced in physiological Results
systems by several redox metal±containing proteins,
including hemoglobin, nitric oxide synthase (NOS), su- Endogenous NOS Activity Can Decrease
peroxide dismutase, and S-nitrosothiols (SNOs), which NMDA Responses
have recently been identified in brain. However, the We sought evidence using digital Ca21 imaging tech-
chemical biology of NO2 remains largely unknown. niques in our rat cerebrocortical cultures for NOS down-
Here, we show that NO2Ðunlike NO´, but reminiscent regulation of NMDA responses. We found that addition
of NO1 transfer (or S-nitrosylation)Ðreacts mainly with of the NOS substrate L-arginine to the medium led to a
Cys-399 in the NR2A subunit of the N-methyl-D-aspar- decrease in NMDA response amplitude (Figure 1) but
tate (NMDA) receptor to curtail excessive Ca21 influx did not affect responses to K1 (50 mM) or kainate (50 mM).
and thus provide neuroprotection from excitotoxic in- This effect was blocked by the NOS inhibitor L-nitro-
sults. This effect of NO2 closely resembles that of arginine. Additional in vitro and in vivo evidence that
NOS, which also downregulates NMDA receptor activ- physiological NOS activity can affect NMDA responses
ity under similar conditions in culture. has been presented (Manzoni and Bockaert, 1993; Ken-
drick et al., 1996), indicating that endogenous form(s) of
Introduction NO-related species can downregulate NMDA receptor
function.
Despite the fact that nitric oxide (NO´) and its redox-
related species are known to mediate a wide range of Endogenously Produced NO2 or Exogenous NO2
physiological activities, the chemical reactions and tar- Donors Decrease NMDA Receptor Responses
get proteins underlying these regulatory processes are Next, we found that enzymatic generation of endoge-
just beginning to be elucidated (Stamler et al., 1992b, nous NO2 or application of exogenous NO2 donors to
1997; Butler et al., 1995). The N-methyl-D-aspartate the cultured cortical neurons also decreased NMDA re-
(NMDA) subtype of glutamate receptor has provided a ceptor activity, as assayed by digital Ca21 imaging and
useful physiological model to test the chemical biology whole-cell recording with patch electrodes (Figures 2
of NO-related species. In particular, S-nitrosylation and 3, respectively). Three donors of NO2 (Oxi-NO, Sulfi-
(transfer of NO1 [nitrosonium ion] to critical thiols) has NO, and Piloty's acid) all exhibited qualitatively similar
been shown to downregulate NMDA channel activity effects in this regard (at millimolar concentrations, these
and thus confer neuroprotection, while under the same donors generate low micromolar levels of NO2) (Fukuto
conditions NO´ does not (Stamler et al., 1992a, 1992b; et al., 1992; Nagasawa et al., 1995; Feelisch and Stamler,
Lipton et al., 1993; Lipton and Stamler, 1994). In contrast, 1996). For example, Oxi-NO inhibited the NMDA-evoked
the activity of NO2 (nitroxyl anion)Ðwhich can be formed [Ca21]i responses in a manner similar to the strong oxi-
dizing agent 5±59-dithiobis-(2-nitrobenzoic acid) (DTNB)
(Figure 2). Piloty's acid, consistent with recent reports³ To whom correspondence should be addressed at the following
present address: Del E. Webb Center for Neuroscience and Aging that it is a better NO´ than NO2 donor at physiological
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La Jolla, CA 92037 (e-mail: slipton@burnham-inst.org). exhibited less of an effect. In a series of experiments in§ These authors contributed equally to this work.
which the sulfhydryl reducing agent dithiothreitol (DTT)‖ Present address: Department of Pharmacology, Ewha Medical
was initially applied to maximize NMDA responsesSchool, 911-1 Mok-6-dong, Yangchun-ku, Seoul 158-750, Republic
of Korea. (Aizenman et al., 1989), subsequent addition of Oxi-NO
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Figure 3. NO2-generating Drugs Inhibit NMDA-Evoked Current Re-
Figure 1. Endogenous NOS Activity Can Attenuate NMDA-Evoked sponses
Responses Inhibition of NMDA-evoked whole-cell currents by Oxi-NO (5 mM)
Addition of the NOS substrate, L-arginine (1 mM), to the bathing and reversal of effect after incubation in DTT (2 mM), as assessed
solution for 20 min resulted in a dramatic decrease in NMDA-evoked in patch-clamp recordings. Note that the inhibitory effect of Oxi-NO
responses, while preincubation in the NOS inhibitor, L-nitro-arginine on NMDA responses was observed on neurons that had not been
(1 mM), prevented this effect, as assessed with digital quantitation previously exposed to DTT.
of [Ca21]i with fura-2 in cultured rat cortical neurons. Control re-
sponses to NMDA (100 mM 1 2 mM glycine for 20 s) prior to the
addition of L-arginine averaged 276 6 12 mM [Ca21]i (mean 6 SEM,
disulfide bonds and removes the NO group (Xu et al.,n 5 60 neurons; *p , 0.01 by Student's t test). This experiment was
replicated five times with similar results. 1998), reversed these inhibitory effects on NMDA re-
sponses. NO2 could conceivably inhibit [Ca21]i re-
sponses other than at the level of the NMDA receptor.
decreased NMDA-evoked [Ca21]i responses by 46% 6 Therefore, to more directly assess the effects of NO2
5% (mean 6 SEM, n 5 6), Sulfi-NO by 32% 6 8% (n 5 on the NMDA receptor, electrophysiological recordings
6), and DTNB by 45% 6 4% (n 5 8). DTT, which reduces were obtained using the patch-clamp technique. During
whole-cell recording performed on neurons that had
not been previously exposed to DTT, Oxi-NO inhibited
NMDA-evoked activity by 28% 6 10% (n 5 4; Figure 3).
In contrast to the inhibitory effects of NO2 on NMDA
responses, kainate-evoked [Ca21]i responses in our cul-
ture system are not modulated by redox reagents or
other NO-related species (Aizenman et al., 1989; Lei et
al., 1992).
Nitroxyl Reactions with Thiol Groups
The electrons in the outer molecular orbital of NO2 are
thought to exist in two distinct excitation states, a lower
energy state, designated the triplet state, and a higher
energy singlet state (Bonner and Stedman, 1996). Impor-
tantly, the reactivities of these species are different.
Singlet NO2 tends to react with thiol groups (Doyle et
al., 1988) to form disulfide and hydroxylamine, whereas
triplet NO2 favors reaction with O2, producing peroxyni-Figure 2. NO2-generating Drugs Inhibit NMDA-Evoked [Ca21]i Re-
trite (ONOO2) (Stamler et al., 1992b; Arnelle and Stamler,sponses
1995; Butler et al., 1995; Bonner and Stedman, 1996).Digital quantitation of [Ca21]i with fura-2 in cultured rat cortical neu-
rons. In the presence of glycine (1 mM) and tetrodotoxin (TTX; 0.5 The latter oxidizes thiols but shows less target selectiv-
mM), 30 mM NMDA elicited large increases in [Ca21]i. Oxi-NO or ity. Recent evidence suggests that the NO2 donor drugs
Piloty's acid at 5 mM were used to generate low micromolar concen- used here generate singlet NO2 (Fukuto et al., 1992;
trations of NO2 (Fukuto et al., 1992; Nagasawa et al., 1995; Feelisch Nagasawa et al., 1995; Bonner and Stedman, 1996; Fee-
and Stamler, 1996). These drugs decreased NMDA responses fol-
lisch and Stamler, 1996; Wink and Feelisch, 1996). Underlowing exposure to 2 mM DTT, but Oxi-NO was much more potent
physiological conditions, nitroxyl can also be producedthan Piloty's acid, producing an effect equivalent to that of 0.5 mM
DTNB; there was no further inhibition of NMDA-evoked responses (presumably in the singlet state), for example, during the
by Oxi-NO after prior oxidation with DTNB. Values are mean 6 SEM generation of met hemoglobin from partially nitrosylated
(*p , 0.05, **p , 0.01 compared to response after DTT, analyzed deoxy hemoglobin (Gow and Stamler, 1998). N-ethylma-
with an analysis of variance [ANOVA] followed by a ScheffeÂ multiple leimide (NEM, #1 mM), which irreversibly alkylates thiol
comparison of means). Dissipation of NO2 from these drugs prior
groups of the NMDA receptor, should prevent the inhibi-to their use by incubating at room temperature for 1 day (labeled
tion of NMDA-evoked responses by singlet NO2 donors.ªold Oxi-NOº and ªold Piloty's acidº) abrogated their effect. This
experiment was repeated eight times with similar results. Indeed, in our experiments following treatment with
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(Figures 5C and 5D). Mutation of NR2A Cys-399 alone
to alanine abrogated approximately 60% of the NO2
effect (Figure 5D). One potential caveat in this approach
is that mutation of cysteine residues can possibly affect
the structural integrity of the receptor. Therefore, as con-
trols, we tested the NMDA and glycine dose-response
curves of these mutants, as well as sensitivity to Mg21
block, to insure the integrity of the agonist site, coago-
nist site, and channel pore. The mutants manifest only
minor effects on these NMDA receptor properties. Taken
together, these findings strongly suggest that NO2 can
react with multiple extracellular cysteine residues on the
NR1 and NR2A subunits of the NMDA receptor.
Lack of Action of NO´
The NO2 donors also generate NO´, albeit in very small
amounts (Fukuto et al., 1992; Nagasawa et al., 1995;
Feelisch and Stamler, 1996). Therefore, to ensure that
the effects of NO2 donors were not due to their produc-Figure 4. Quantification of Digital Imaging to Show Irreversible Al-
tion of NO´, we performed control experiments using thekylation of Thiol Groups with NEM Prevents the Effect of NO2 on
NMDA-Evoked [Ca21]i Responses more specific NO´ donors, diethylamine-NO (DEA/NO)
and spermine/NO (SPER/NO). With the use of a specificDTT increased NMDA-evoked responses, and NO2 donors de-
creased them. Alkylation of thiol groups with NEM (1 mM) prevented NO´-sensing electrode (WPI) (Lipton et al., 1993), we
the subsequent inhibition of NMDA responses by the various oxidiz- calibrated the concentrations of these NO´ donors to
ing agents, including DTNB or the NO2 donors. Values are mean 6 generate similar or slightly greater amounts of NO´ over
SEM (**p , 0.01 compared to NMDA response after DTT).
a 2 min period compared to the NO2 donors (Table 1).
At these concentrations, neither DEA/NO nor SPER/NO
influenced the NMDA-evoked responses (e.g., Figure 6),
NEM, NMDA responses were not altered by Oxi-NO,
consistent with our previous findings that NO´ itself does
Piloty's acid, or DTNB (Figure 4).
not downregulate NMDA receptor activity (Lipton et al.,
In additional experiments aimed at proving that NO2
1993). Thus, NO2 and not NO´ appears to be responsible
reacted specifically with thiol groups on the NMDA re-
for the inhibitory effect on the NMDA receptor±channel
ceptor, we studied recombinant NR1/NR2A receptors
complex described here.
expressed in Xenopus oocytes. In this system, as in
native cerebrocortical neurons, NO2 decreased NMDA
responses recorded under two-electrode voltage clamp Production of Nitroxyl Anion in Biological Tissues
(Figure 5A, upper trace). We then used methanethiosul- As recently shown, hemoglobin can produce NO2 under
fonate derivatives that react specifically and rapidly with physiological conditions (Gow and Stamler, 1998). Addi-
thiol groups to form mixed disulfides (Akabas et al., tionally, it was reported that NO2 is a physiological prod-
1992). Prior incubation with the thiol-specific methane- uct of the enzyme neuronal nitric oxide synthase (nNOS)
sulfonate, 2-(trimethlylammonium)ethyl methanethiosulfo- and S-nitrosoglutathione (GSNO) (Hobb et al., 1994;
nate (MTSET), prevented inhibition of NMDA responses Zhao et al., 1995; Schmidt et al., 1996; Mayer et al.,
by the NO2-generating drugs (Figures 5A, lower trace, 1998), the latter being present in the brain at micromolar
and 5B). These findings indicate that the predominant concentrations (Hogg et al., 1996; Kluge et al., 1997).
mechanism of inhibition of NMDA responses by the NO2 Endogenous NO2 can also be generated from NO´ by
donors involves interaction with free thiol groups. More- other redox metal±containing enzymes, such as SOD
over, compared to other methanethiosulfonate deriva- [Cu(I)] (Equation 1) (Murphy and Sies, 1991).
tives, MTSET is a larger, charged agent that does not
easily permeate cell membranes. The fact that bath ap- Enz[M] 1 NO´ ←→ Enz[M1] 1 NO2 (1)
plication of this charged compound prevented the effect
of NO2 suggests therefore that the critical thiol groups where Enz indicates enzyme and M indicates metal [for
copper, Cu(I) ←→ Cu(II); for iron, Fe(II) ←→ Fe(III)].are located extracellularly on the NMDA receptor.
To study this possibility further, we performed site- We confirmed that SOD[Cu(I)] could support the re-
duction of NO´ by assaying the conversion of met myo-directed mutagenesis of extracellular cysteine residues.
We found that the following cysteine residues were criti- globin to nitrosyl myoglobin (Murphy and Sies, 1991;
Arnelle and Stamler, 1995). We then took advantage ofcal for the response to NO2: NR2A Cys-87, Cys-320, and
Cys-399; NR1 Cys-744 and Cys-798. When we mutated the reaction in Equation 1 to produce endogenous NO2
in our culture system by reacting reduced SOD (SODthese multiple cysteine residues on NR1 and NR2A sub-
units, the inhibition of NMDA-evoked currents by the [Cu(I)]) with NO´, using DEA/NO as the NO´ donor (Mar-
agos et al., 1991). Under these conditions, NO2 wasNO2-generating agent Piloty's acid was virtually abol-
ished [inhibition of 1% 6 1%, n 5 6 for NR1(C744A, apparently generated in its triplet energy state since
we did not detect hydroxylamine, as would have beenC798A)/NR2A(C87A,C320A,C399A) receptors versus
19% 6 3%, n 5 6 for wild-type NR1/NR2A receptors] expected had singlet NO2 been produced (Arnelle and
Neuron
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Figure 5. NO2 Inhibits NMDA Evoked Currents in NR1/NR2A Receptors, MTSET Prevents the NO2 Effect, and Specific Extracellular Cysteine
Residues on NR1/NR2A Underlie the NO2 Effect
(A) Upper trace: NMDA-evoked currents (by 200 mM NMDA plus 100 mM glycine) are inhibited by a 3 min application of the NO2-generating
drug Oxi-NO (3 mM) in oocytes expressing NR1/NR2A receptors. Following washout of Oxi-NO, the decrease in NMDA-evoked currents
persisted (greater than 30 min, the duration of the experiment). Lower trace: in a different oocyte, addition of MTSET (0.5 mM for 2 min)
prevented inhibition of NMDA-evoked currents by Oxi-NO (3 mM for 3 min). Currents were recorded at room temperature at a holding potential
of 280 mV (pH 7.5).
(B) Inhibition of NR1/NR2A receptor currents by Oxi-NO, expressed as a percentage of the response to NMDA prior to Oxi-NO application
(mean 6 SEM, n 5 4 for each group). Inhibition by Oxi-NO after MTSET exposure was significantly less than that without MTSET treatment
(*p , 0.01 by Student's t test).
(C) Current tracings showing the absence of inhibition of NMDA-evoked currents by the NO2-generating drug Piloty's acid (10 mM) in oocytes
expressing NR1(C744A,C798A)/NR2A(C87A,C320A,C399A) mutant receptors.
(D) Inhibition of NMDA-evoked currents by Piloty's acid in wild-type or mutant NR1/NR2A receptors expressed as a percentage of the response
to NMDA prior to Piloty's acid application (mean 6 SEM, n 5 6 for each group). Inhibition by Piloty's acid of NR1/NR2A(C399A) receptor
responses was significantly less than that of wild-type NR1/NR2A receptors (*p , 0.01, ANOVA followed by Fisher's PLSD test). Additionally,
inhibition by Piloty's acid of NR1(C744A,C798A)/NR1(C87A,C320A,C399A) receptor responses was significantly less than that of NR1/
NR2A(C399A) receptors (²p , 0.05).
Stamler, 1995; Gow and Stamler, 1998). NO2 generated (Kim et al., 1996), whereas it is neurodestructive at higher
concentrations (Beckman et al., 1990; Dawson et al.,in this manner decreased NMDA-evoked [Ca21]i re-
sponses by 25% 6 5% (n 5 4, Figure 6), similar to 1993; Lipton et al., 1993). We therefore speculate that
triplet NO2 is acting here via formation of low concentra-the NO2-generating drugs. As controls, neither DEA/NO
alone, SOD[Cu(I)] alone, nor the combination of SOD tions of ONOO2 to downregulate NMDA receptor ac-
tivity.[Cu(II)] plus DEA/NO affected NMDA-evoked responses.
Triplet NO2 does not react directly with thiol groups
but can react with O2, forming peroxynitrite (ONOO2) Nitroxyl Attenuates NMDA Receptor-Mediated
Excitotoxicity(Stamler et al., 1992b; Arnelle and Stamler, 1995; Butler
et al., 1995), which does react with thiol (Radi et al., In the following experiments, the NO2 donors signifi-
cantly ameliorated NMDA receptor-mediated neurotox-1991). At low concentrations, peroxynitrite decreases
NMDA receptor activity by oxidizing critical thiol groups icity, consistent with the finding that NO2 downregulates
Nitroxyl Attenuates NMDA Activity
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Table 1. NO´ Production from Various NO Group Donors
AUC (mM * 2 min)
Drug (Concentration) (mean 6 SEM) n
Spermine/NO (200 mM) 1.28 6 0.14 9
DEA /NO (20 mM) 2.38 6 0.38 5
Piloty's acid (5 mM) 0.82 6 0.18 3
Sulfi-NO (5 mM) 0.90 6 0.06 4
Oxi-NO (5 mM) 1.46 6 0.44 4
The concentrations of the NO´ donors, spermine/NO and DEA /NO,
were chosen to generate amounts of NO´ that were approximately
equal to or slightly greater than that the NO´ production of the NO2-
generating drugs, Oxi-NO, Sulfi-NO, and Piloty's acid (the latter is
a poor generator of NO2). Thus, the NO´ donors serve to ensure that
the effects of the NO2-generating drugs were not due to NO´. The
total NO´ production during a 2 min incubation was determined by
the area under the curve (AUC) of NO´ versus time, as read out by an
NO´-sensitive electrode to a digital meter and graphed electronically.
AUC values were calculated by the method of trapezoids and ex-
pressed as the mean 6 SEM for n experiments.
excessive NMDA-evoked responses (Figure 7A). In 18
of 22 experiments, similar in design to that illustrated in
Figure 7, the NO2 donors Oxi-NO, Sulfi-NO, or Piloty's
Figure 7. Oxi-NO, NO2, but not DEA/NO, NO´, Ameliorates NMDAacid (1±5 mM) afforded protection from NMDA-induced
Receptor±Mediated Toxicity of Rat Cortical Neurons in Cultureneurotoxicity (p , 0.002 by the Sign test). To be certain
(A) To test the effects of an NO2 donor on neuronal survival, cerebro-of the identity of the redox form of the NO group involved
cortical cultures were placed in Earle's balanced salt solution (EBSS)
in this neuroprotective effect, we incubated the cortical and preincubated in 1 mM Oxi-NO (or control solution) for 2 min
cultures in the NO´ donor DEA/NO (20 mM), which pro- prior to the addition of NMDA. Cells were then exposed to 300 mM
duces a greater amount of NO´ than any of the NO2- NMDA (plus 10 mM glycine) for 10 min, rinsed, and placed back
in EBSS in the incubator overnight prior to the determination ofgenerating drugs (Table 1). At this concentration, DEA/
neurotoxicity. Neuronal damage was then assessed by measuring
the release of lactate dehydrogenase (LDH) and verified by cell
counts, as previously described (Koh and Choi, 1987; Lipton et
al., 1993). Data are expressed as mean 6 SEM for an experiment
performed in triplicate on sibling cultures. The asterisk indicates
significantly different compared to the group exposed to NMDA plus
Oxi-NO (p , 0.05 by Student's t test).
(B) Addition of DEA/NO (20 mM) prior to NMDA and glycine exposure
did not rescue neurons from damage. Similar treatment with DEA/
NO alone had no effect on viability, as assessed after overnight
incubation as in (A), above. The asterisk indicates significantly differ-
ent compared to the group exposed to control or to DEA/NO (p ,
0.01, ANOVA followed by a ScheffeÂ multiple comparison of means).
NO had no effect on the viability of the neurons and did
not protect from NMDA-induced toxicity (Figure 7B).
Together, these findings suggest that NO2 is associated
with significant attenuation of NMDA receptor-mediated
neurotoxicity.
Figure 6. NO2, Generated from NO´ by SOD[Cu(I)], Decreases
NMDA-Evoked [Ca21]i Responses Discussion
DEA/NO was used as the NO´ donor (Maragos et al., 1991); NO´
reacts with SOD[Cu(I)] (equivalent to reduced SOD, labeled Red- Our results suggest that NO2 can react with critical thiol
SOD in the figure) to generate NO2. Neither DEA/NO alone (20 mM), groups of the NMDA receptor to downregulate its activ-
SOD[Cu(I)] alone (50 U/ml), nor SOD[Cu(II)] (50 U/ml) in the presence ity (Figure 8). The evidence includes the fact that the
of DEA/NO affected NMDA-evoked responses (SOD[Cu(II)], equiva-
specific thiol-reacting agent MTSET as well as the thiol-lent to oxidized SOD or Oxi-SOD, does not react with DEA/NO).
alkylating agent NEM prevent the effect of nitroxyl onValues in the calcium imaging panels are expressed as the mean 6
SEM, normalized to the first NMDA response following a 2 min NMDAR activity, and site-directed mutagenesis of extra-
exposure to DTT; this response was assigned a value of 100% cellular cysteine residues abrogates the effect of NO2.
(indicated by the arrow). The maximum [Ca21]i response to NMDA We show, moreover, that multiple cysteine residues of
following incubation in DTT in any one neuron was z1 mM. Re- the NMDA receptor, both on the NR1 and NR2A sub-
sponses to NMDA that were statistically smaller than those obtained
units, may participate in NO2 reactions with a varyingimmediately after the first exposure to DTT are indicated by asterisks
degree of effect. Involvement of several cysteines may(*p , 0.01, analyzed with an ANOVA followed by a ScheffeÂ multiple
comparison of means). Values are mean 6 SEM. be the general case in such receptors, whereby they
Neuron
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may provide a molecular basis for recognizing and dif-
ferentiating oxidative from nitrosative signals (Xu et al.,
1998). In this case, most of the NO2 effect derives from
modification of a single cysteine at position 399 of the
NR2A subunit.
The reaction mechanisms for singlet and triplet NO2
are different, and the identity of the function-regulating
species in biological fluids is likely to be system and
source dependent (Wink and Feelisch, 1996; Bonner and
Stedman, 1996). However, the resulting oxidation of thiol
is reminiscent of the reactions of nitrosothiols, which
act as nitrosyl (NO1) donors to downregulate NMDA
channel activity. Such reactions with critical thiol group(s)
of the NMDA receptor afford protection from excitotoxic
damage to neurons (Lipton et al., 1993; Lipton and
Stamler, 1994; Sullivan et al., 1994) and stand in stark
contrast to the neurodestructive potential of NO´-related
pathways, as delineated previously (Beckman et al.,
1990; Dawson et al., 1991, 1993; Lipton et al., 1993;
Bonfoco et al., 1995). Inasmuch as nNOS produces NO1
and NO2 activity (Stamler et al., 1992b; Stamler, 1994;
Hobb et al., 1994; Zhao et al., 1995; Schmidt et al., 1996;
Kluge et al., 1997), our results explain downregulation
of NMDA responses by virtue of reaction with critical
cysteines. Recently, we and others have demonstrated
additional protein thiol targets for the NO group in addi-
tion to the NMDAR that may also contribute to neuropro-
tection. These targets include critical cysteine residues
in p21ras and the active site of caspase enzymes (Dim-
meler et al., 1997; Lander et al., 1997; Melino et al., 1997;
Ogura et al., 1997; Tenneti et al., 1997; Yun et al., 1998;
Mannick et al., 1999).
nNOS has recently been colocalized with the NMDA
Figure 8. Proposed Mechanism for the Action of NO2, Nitroxyl receptor through PDZ domain interactions (Brenman et
Anion
al., 1996)Ðwhereby it can achieve local action. Indeed
It has been proposed that NO2 can be generated in two forms, NOH
the physical proximity of nNOS and the NMDA receptor,or HNO, both of which may exist in the triplet or singlet states
the cellular experiments by us and others showing NOS(Bonner and Stedman, 1996; Wink and Feelisch, 1996). For example,
downregulation of NMDA receptor activity, and ourin the singlet state, two antibonding electrons occupy a single outer
p* (pi antibonding molecular orbital), with spins opposed. In the chemical data on NO1 and NO2 are all internally consis-
triplet state, the two p* antibonding orbitals each contain an electron tent and indicate that NO1 or NO2 regulation of the
with spins aligned (with a z component of electron spin of 11, 0, NMDA receptor, as well as of other protein targets (Ten-
or 21; hence, the designation ªtriplet stateº). neti et al., 1997; Yun et al., 1998), is likely to be physiolog-
(A) In the singlet state, NO2/HNO (pKa 4.7) can react with critical ically relevant. It is also intriguing to speculate on thethiols of the NMDA receptor to yield an R-SNH-OH derivative (A1)
potential role of NO2 in localizing ªNOº signals in a wayor disulfide (A2), in which case hydroxylamine (NH2OH) is also formed
that is inherently resistant to neurotoxic mechanisms.(Doyle et al., 1988; Arnelle and Stamler, 1995). These reactions would
That NO2 can ameliorate excitotoxic neuronal damagedownregulate NMDA receptor activity (Lipton et al., 1993; Sullivan et
al., 1994). The presence of a disulfide bond was recently confirmed in raises the possibility that exogenous donor drugs may
the crystal structure of GluR2 receptors, which revealed the forma- be used for therapeutic gain in a wide variety of neuro-
tion of disulfide between cysteine residues homologous to NR1 Cys- logic disorders that are mediated, at least in part, by
744 and Cys-798 (Armstrong et al., 1998), and this may also be true excessive stimulation of NMDA receptors (Choi, 1988;
for NR2A Cys-87 and Cys-320 (Y.-B. Choi et al., 1997, Soc. Neurosci.,
Meldrum and Garthwaite, 1990; Dawson et al., 1991;abstract). To confirm this type of reaction scheme here, we have
Lipton and Rosenberg, 1994).shown that hydroxylamine forms when an NO2-generating drug re-
acts with vicinal thiols. Thus, reactions of singlet NO2 are likely to
Experimental Proceduresbe neuroprotective, at least under our conditions.
(B) Triplet NO2, rather than reacting directly with thiol, tends to react
Cerebrocortical Cultureswith molecular oxygen to form peroxynitrite (ONOO2) (Bonner and
Cortical cultures of mixed neurons and glia were derived from em-Stedman, 1996), which can also oxidize thiols to disulfide (B1) (Radi
bryonic (fetal day 15 or 16) Sprague-Dawley rats as described pre-et al., 1991); this reaction can be reversed with DTT. Alternatively,
viously (Lei et al., 1992; Lipton et al., 1993). Briefly, following dissoci-ONOO2 can oxidize thiol to produce an -OH modification of sulfur
ation in 0.027% trypsin, cerebral cortical cells were plated at a(a sulfenic acid or R-SOH, as shown in [B2]), which is also reversible
with DTT (Becker et al., 1998; Stamler and Hausladen, 1998). Indeed,
we have demonstrated that at low concentrations peroxynitrite
downregulates NMDA receptor activity, apparently reacting at a redox roprotectiveÐare likely to be more tenuous in vivo, as peroxynitrite
modulatory site(s) on the receptor since DTT can reverse this effect is a powerful oxidant that has been shown to account for NO-related
(Kim et al., 1996). Such effects of triplet NO2/O2Ðwhile supportive neurotoxicity (Beckman et al., 1990; Dawson et al., 1993; Lipton et
of the molecular mechanism entertained here and theoretically neu- al., 1993; Bonfoco et al., 1995).
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density of 4.5 3 105 per 35 mm dish containing poly-L-lysine-coated Preparation of Xenopus Oocytes and Injection of cRNA
Frog oocytes of stages V or VI were surgically removed from theglass cover slips in Dulbecco's modified Eagle's medium with Ham's
F12, and heat-inactivated iron-supplemented calf serum (HyClone) ovaries of Xenopus laevis. Lumps of about 100 oocytes were incu-
bated with 580 U/ml (2 mg/ml) collagenase type I (Sigma) for 2 hrat a ratio of 8:1:1. After 15 days in culture (when the astrocyte layer
had become confluent), the cultures were treated with cytosine in Ca21-free frog Ringer's solution (82.5 mM NaCl, 2 mM KCl, 1 mM
MgCl2, 5 mM HEPES [pH 7.5 with NaOH]). After slow agitation toarabinoside for 72 hr. The culture medium was replenished three
times weekly. Cultures were incubated at 368C in a 5% CO2/95% remove the follicular cell layer, the oocytes were washed extensively
with Ca21-free frog Ringer's solution. Oocytes were maintained atair humidified atmosphere. The cultures were used for experiments
at room temperature (218C±248C) 3±4 weeks after plating. Neurons 188C in frog Ringer's solution (96 mM NaCl, 2 mM KCl, 1.8 mM
CaCl2, 1 mM MgCl2, 5 mM HEPES [pH 7.5 with NaOH]) supplementedcould be reliably identified by morphological criteria under phase-
contrast optics, as later confirmed by patch-clamp recording. To with 550 mg/L sodium pyruvate as a carbon source and 100 mg/ml
gentamicin. Oocytes were injected with up to 10 ng of cRNA of eachpermit physiology experiments (calcium imaging or patch-clamping)
under normal room air conditions, just prior to a recording session subunit 24 hr later, using a 10 ml Drummond microdispenser under
visual control with a dissecting microscope.the culture medium was exchanged for a solution based on Hanks'
balanced salts. The Hanks' saline consisted of: 137.6 mM NaCl; 1
mM NaHCO3; 0.34 mM Na2HPO4; 5.36 mM KCl; 0.44 mM KH2PO4;
Two-Electrode Voltage Clamp Recording of Oocytes1.25±2.5 mM CaCl2; 5 mM HEPES; 22.2 mM dextrose (adjusted to
Two days after injection, oocytes were recorded in frog Ringer'spH 7.2 with 0.3 M NaOH).
solution under two-electrode voltage clamp at 280 mV. Recordings
were performed with an Oocyte Clamp OC-725b amplifier (Warner
Instrument) using MacLab v3.5 software (ADI Instruments). Voltage-Nitroxyl-Producing Drugs, Calcium Imaging,
sensing electrodes had a resistance of 1±4 MV and current-injectingand Patch-Clamp Recording
electrodes, 0.5±1 MV. Both were filled with 3 M KCl. Oocytes wereNO2-generating drugs included Oxi-NO (sodium trioxodinitrate, also
continuously superfused with a solution containing 90 mM NaCl, 1known as Angeli's salt), Sulfi-NO (N-nitrosohydroxylamine-N-sulfo-
mM KCl, 10 mM HEPES, 1.5 mM BaCl2, and 100 mM glycine (pHnate/ammonium salt), and Piloty's acid (benzenesulfohydroxamic
7.5). Barium was used as the divalent cation, rather than calcium,acid) (Fukuto et al., 1992; Nagasawa et al., 1995; Zamora et al.,
in order to minimize secondary activation of calcium-activated Cl21995; Feelisch and Stamler, 1996). Digital [Ca21]i imaging was per-
current (Leonard and Kelso, 1990). Drugs dissolved in frog Ringer'sformed with standard methods, as previously described in this prep-
solution were applied by superfusion at a flow rate of z2 ml/min inaration (Lei et al., 1992; Lipton et al., 1993). All redox reagents,
a z100 ml chamber with an array of pipettes similar to the sewerincluding DTT (2 mM), DTNB (0.5 mM), NEM (1 mM), and the NO2-
pipe system used in patch-clamp recording in order to achievegenerating drugs, were superfused for 2 min, washed away with
relatively rapid solution exchange. Using a concentration jump para-nominally Mg21-free Hanks' buffered saline solution for 3±4 min,
digm with Mg21, we measured a time constant of z3 s for completeand then the NMDA-elicited [Ca21]i responses were monitored. DTT,
solution exchange in the recording chamber.DTNB, and NO2 donors, either during incubation or after thorough
washout, did not alter basal [Ca21]i.
NMDA-evoked whole-cell currents were recorded using standard Physiological Generation of Nitroxyl Anion
patch-clamp techniques, as previously described in this preparation in Cerebrocortical Cultures
(Lei et al., 1992; Lipton et al., 1993). Cortical neurons were voltage- Cortical neurons were incubated for 2 min in a mixture of 20 mM
clamped at 260 mV and continuously superfused in Mg21-free DEA/NO (an NO´ generator) and 50 U/ml SOD[Cu(I)] to mimic the
Hanks' balanced salt solution with 1.25 mM Ca21, 1 mM TTX, and 1 physiological reduction of NO´ to NO2 that can be achieved by
mM glycine (pH 7.2). The pipette-filling solution contained 120 mM several redox enzymes including nNOS and SOD. Endogenous NO2
CsCl, 20 mM tetraethylammonium chloride, 2 mM MgCl2, 1 mM can be generated from NO´ by reduced SOD, as described previously
CaCl2, 2.25 mM EGTA, and 10 mM Cs-HEPES (pH 7.2). NMDA (200 (Murphy and Sies, 1991) and confirmed by us. After thorough rinsing
mM) was puffed onto neurons with a pneumatic pipette. Under our in Mg21-free Hanks' buffered salt solution, NMDA-elicited [Ca21]iconditions, NO´ donors alone did not affect NMDA-evoked re- responses were assessed. The concentration of NO´ was measured
sponses (for further discussions of this point, see Manzoni et al., with an NO´-selective electrode (WPI), as previously detailed (Lipton
1992, and Fagni et al., 1995, vis-aÂ -vis Lipton et al., 1993, 1996, and et al., 1993). These measurements were performed under the same
Lipton, 1999). conditions as the electrophysiological recordings, that is, in Hanks'
solution in the presence of the cells in culture. The generation of
hydroxylamine during the reaction of singlet NO2 with thiol to formcRNA Synthesis
disulfide was followed spectrophotometrically, as previously de-cDNA for NR1±1a (the exclusive splice variant of NR1 used in these
scribed (Arnelle and Stamler, 1995; Gow and Stamler, 1998).studies) and for NR2A were the kind gifts of Shigetada Nakanishi,
Stephen Heinemann, and Peter Seeburg. The template was pre-
pared from a circular plasmid cDNA by linearizing in the 39 untrans- Neurotoxicity Assays
lated region with NheI (for NR1) or EcoRV (for NR2A). cRNA that For the neurotoxicity experiments, the normal culture medium was
incorporates 59 cap analog (m7G[59]ppp[59]G) was transcribed from exchanged at room temperature for Earle's Balanced Salt Solution
1 mg of linearized template in vitro by T7 (for NR1) or T3 (for NR2A) (EBSS) without phenol red (GIBCO #310±4015AG). Some cultures
RNA polymerase according to the Ambion (mMessage mMachine) were pretreated with NO-related species a couple of minutes prior
protocol. cRNA concentrations were determined by measuring the to the addition of NMDA. The cultures were then incubated in 300
optical density at 260 nm, and the purity of the cRNA was assessed mM NMDA plus 10 mM glycine and assayed for neurotoxicity after
by agarose gel electrophoresis. overnight incubation by monitoring leakage of lactate dehydroge-
nase (LDH) into the medium with verification by cell counts, as
previously described (Koh and Choi, 1987; Lei et al., 1992; Lipton
Site-Directed Mutagenesis et al., 1993; Bonfoco et al., 1995).
Mutants were generated using the Chameleon double-stranded site-
directed mutagenesis kit based on T7 DNA polymerase (Strata-
gene). Mutants were verified by sequencing. The NR1 mutants, Acknowledgments
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